MARSHFIELD, Wis., Aug. 5, 2020 /PRNewswire/ — PreventionGenetics is excited to announce the availability of their new whole genome sequencing (WGS) test, PGnome®. Prices start at...read more
Latest news and articles
Blackstone to Acquire Ancestry®, Leading Online Family History Business, for $4.7 Billion
New York, August 5, 2020 – Blackstone (NYSE:BX) today announced that private equity funds managed by Blackstone (“Blackstone”) have reached a definitive agreement to acquire Ancestry® from Silver Lake, GIC...read more
Genuity Science Announces Strategic Collaboration with Nashville Biosciences
BOSTON, Aug. 4, 2020 /PRNewswire/ — Genuity Science, a U.S.-headquartered contract genomics and data-sourcing, -analytics and -insights organization, today announces an agreement with Nashville...read more
Sema4 Closes $121 Million Series C Led by BlackRock
Sema4’s post-money valuation exceeds $1 billion STAMFORD, CT — July 28, 2020 — Sema4, a patient-centered health intelligence company, today announced that funds managed by BlackRock led its oversubscribed Series C...read more
Illumina Acquires Enancio’s Compression Software
Reduces genomic data storage and transfer costs associated with the data deluge 14 July 2020 In 2019, the volume of genomic data generated by Illumina’s global installed base of more than 15,000 sequencing systems...read more
Illumina Launches TruSight Software Suite to Accelerate the Identification of Genetic Diseases
SAN DIEGO–(BUSINESS WIRE)– Illumina, Inc. (NASDAQ: ILMN) is bringing turn-key data analysis solutions to accelerate and facilitate the adoption of whole-genome sequencing with the launch of the TruSight™...read more
Genomics England launches next-generation research platform central to UK COVID-19 response
British tech company Lifebit and Amazon Web Services to support a dedicated environment for researchers working on COVID-19 vaccines and treatments Genomics England (GEL) has today launched a next-generation genomic...read more
WuXi NextCODE Restructures and Becomes Genuity Science
BOSTON, June 23, 2020 /PRNewswire/ — WuXi NextCODE today announced plans to restructure its operations and governance in order to best position the company for future growth, ground-breaking...read more
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
Combination to bring germline and somatic testing, liquid biopsy and tissue genomic profiling onto a single platform to offer patients a full suite of cancer testing for risk, therapy optimization and personalized...read more
Foundation Medicine Acquires Lexent Bio, Inc., to Accelerate Liquid Biopsy Research and Development, and Advance Cancer Care
Acquisition will expand Foundation Medicine’s multiomics capabilities, including the adoption of DNA methylation to evaluate cancer progression in broader patient populations CAMBRIDGE, Mass.–(BUSINESS...read more
